170 related articles for article (PubMed ID: 21083348)
1. Utilization of DBS within drug discovery: development of a serial microsampling pharmacokinetic study in mice.
Clark GT; Haynes JJ; Bayliss MA; Burrows L
Bioanalysis; 2010 Aug; 2(8):1477-88. PubMed ID: 21083348
[TBL] [Abstract][Full Text] [Related]
2. DBS sampling can be used to stabilize prodrugs in drug discovery rodent studies without the addition of esterase inhibitors.
D'Arienzo CJ; Ji QC; Discenza L; Cornelius G; Hynes J; Cornelius L; Santella JB; Olah T
Bioanalysis; 2010 Aug; 2(8):1415-22. PubMed ID: 21083342
[TBL] [Abstract][Full Text] [Related]
3. Utilization of dried blood spots within drug discovery: modification of a standard DiLab(®) AccuSampler(®) to facilitate automatic dried blood spot sampling.
Clark GT; Giddens G; Burrows L; Strand C
Lab Anim; 2011 Apr; 45(2):124-6. PubMed ID: 21355022
[TBL] [Abstract][Full Text] [Related]
4. Perforated dried blood spot accurate microsampling: the concept and its applications in toxicokinetic sample collection.
Li F; Ploch S; Fast D; Michael S
J Mass Spectrom; 2012 May; 47(5):655-67. PubMed ID: 22576879
[TBL] [Abstract][Full Text] [Related]
5. Exploring the feasibility of using the DBS technique for metabolite radioprofiling.
Wang L; Zeng Z; Emmons G
Bioanalysis; 2010 Aug; 2(8):1365-71. PubMed ID: 21083337
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetic considerations as to when to use dried blood spot sampling.
Emmons G; Rowland M
Bioanalysis; 2010 Nov; 2(11):1791-6. PubMed ID: 21083484
[TBL] [Abstract][Full Text] [Related]
7. Determination of mycophenolic acid and its phenyl glucuronide in human plasma, ultrafiltrate, blood, DBS and dried plasma spots.
Heinig K; Bucheli F; Hartenbach R; Gajate-Perez A
Bioanalysis; 2010 Aug; 2(8):1423-35. PubMed ID: 21083343
[TBL] [Abstract][Full Text] [Related]
8. What is next for dried blood spots?
Ji QC; Liu G; D'Arienzo CJ; Olah TV; Arnold ME
Bioanalysis; 2012 Aug; 4(16):2059-65. PubMed ID: 22946921
[TBL] [Abstract][Full Text] [Related]
9. Direct analysis in real time coupled with dried spot sampling for bioanalysis in a drug-discovery setting.
Crawford E; Gordon J; Wu JT; Musselman B; Liu R; Yu S
Bioanalysis; 2011 Jun; 3(11):1217-26. PubMed ID: 21649498
[TBL] [Abstract][Full Text] [Related]
10. Perspectives on microsampling: DBS.
Viswanathan CT
Bioanalysis; 2012 Jun; 4(12):1417-9. PubMed ID: 22793026
[TBL] [Abstract][Full Text] [Related]
11. Determination of naproxen using DBS: evaluation & pharmacokinetic comparison of human plasma versus human blood DBS.
Youhnovski N; Michon J; Latour S; Mess JN; Bergeron A; Furtado M; Rufiange M; Guibord P; Lefebvre M; Macarthur RB; Garofolo F
Bioanalysis; 2010 Aug; 2(8):1501-13. PubMed ID: 21083350
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of matrix microsampling methods for therapeutic drug candidate quantification in discovery-stage rodent pharmacokinetic studies.
Soto M; Pham R; Almon V; Wagner M; Primack R; Ponce M; Meyer J; James CA; Salyers KL; Retter MW
Bioanalysis; 2014 Aug; 6(16):2135-46. PubMed ID: 25331858
[TBL] [Abstract][Full Text] [Related]
13. Application of DBS for quantitative assessment of the peptide Exendin-4; comparison of plasma and DBS method by UHPLC-MS/MS.
Kehler JR; Bowen CL; Boram SL; Evans CA
Bioanalysis; 2010 Aug; 2(8):1461-8. PubMed ID: 21083346
[TBL] [Abstract][Full Text] [Related]
14. Discovery pharmacokinetic studies in mice using serial microsampling, dried blood spots and microbore LC-MS/MS.
Rahavendran SV; Vekich S; Skor H; Batugo M; Nguyen L; Shetty B; Shen Z
Bioanalysis; 2012 May; 4(9):1077-95. PubMed ID: 22612688
[TBL] [Abstract][Full Text] [Related]
15. Merck's perspective on the implementation of dried blood spot technology in clinical drug development - why, when and how.
Xu Y; Woolf EJ; Agrawal NG; Kothare P; Pucci V; Bateman KP
Bioanalysis; 2013 Feb; 5(3):341-50. PubMed ID: 23394700
[TBL] [Abstract][Full Text] [Related]
16. Evaluating and defining sample preparation procedures for DBS LC-MS/MS assays.
Liu G; Patrone L; Snapp HM; Batog A; Valentine J; Cosma G; Tymiak A; Ji QC; Arnold ME
Bioanalysis; 2010 Aug; 2(8):1405-14. PubMed ID: 21083341
[TBL] [Abstract][Full Text] [Related]
17. Facilitating pharmacokinetic studies in children: a new use of dried blood spots.
Patel P; Mulla H; Tanna S; Pandya H
Arch Dis Child; 2010 Jun; 95(6):484-7. PubMed ID: 20501544
[TBL] [Abstract][Full Text] [Related]
18. Assessment of DBS technology for the detection of therapeutic antibodies.
Prince PJ; Matsuda KC; Retter M; Scott G
Bioanalysis; 2010 Aug; 2(8):1449-60. PubMed ID: 21083345
[TBL] [Abstract][Full Text] [Related]
19. Updates from the EBF DBS--microsampling consortium.
Timmerman P; White S; Cobb Z; de Vries R; Thomas E; van Baar B; Smith C; Zimmer D; Delrat P; Smeraglia J; Lüdtke S
Bioanalysis; 2012 Aug; 4(16):1969-70. PubMed ID: 22946911
[No Abstract] [Full Text] [Related]
20. Study to assess the effect of age of control human and animal blood on its suitability for use in quantitative bioanalytical DBS methods.
Abu-Rabie P; Spooner N
Bioanalysis; 2010 Aug; 2(8):1373-84. PubMed ID: 21083338
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
